These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 11994434)

  • 1. Immunostimulatory CpG-DNA activates murine microglia.
    Dalpke AH; Schäfer MK; Frey M; Zimmermann S; Tebbe J; Weihe E; Heeg K
    J Immunol; 2002 May; 168(10):4854-63. PubMed ID: 11994434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunostimulatory activity of CpG oligonucleotides on microglial N9 cells is affected by a polyguanosine motif.
    Zhang Z; Guo K; Schluesener HJ
    J Neuroimmunol; 2005 Apr; 161(1-2):68-77. PubMed ID: 15748945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity.
    Whitmore MM; DeVeer MJ; Edling A; Oates RK; Simons B; Lindner D; Williams BR
    Cancer Res; 2004 Aug; 64(16):5850-60. PubMed ID: 15313929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA.
    Wagner M; Poeck H; Jahrsdoerfer B; Rothenfusser S; Prell D; Bohle B; Tuma E; Giese T; Ellwart JW; Endres S; Hartmann G
    J Immunol; 2004 Jan; 172(2):954-63. PubMed ID: 14707068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colony-stimulating factor-1 suppresses responses to CpG DNA and expression of toll-like receptor 9 but enhances responses to lipopolysaccharide in murine macrophages.
    Sweet MJ; Campbell CC; Sester DP; Xu D; McDonald RC; Stacey KJ; Hume DA; Liew FY
    J Immunol; 2002 Jan; 168(1):392-9. PubMed ID: 11751985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
    Datta N; Mukherjee S; Das L; Das PK
    Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation.
    Gursel I; Gursel M; Yamada H; Ishii KJ; Takeshita F; Klinman DM
    J Immunol; 2003 Aug; 171(3):1393-400. PubMed ID: 12874230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets.
    Hemmi H; Kaisho T; Takeda K; Akira S
    J Immunol; 2003 Mar; 170(6):3059-64. PubMed ID: 12626561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo role of p38 mitogen-activated protein kinase in mediating the anti-inflammatory effects of CpG oligodeoxynucleotide in murine asthma.
    Choudhury BK; Wild JS; Alam R; Klinman DM; Boldogh I; Dharajiya N; Mileski WJ; Sur S
    J Immunol; 2002 Nov; 169(10):5955-61. PubMed ID: 12421981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunostimulatory CpG-modified plasmid DNA enhances IL-12, TNF-alpha, and NO production by bovine macrophages.
    Shoda LK; Kegerreis KA; Suarez CE; Mwangi W; Knowles DP; Brown WC
    J Leukoc Biol; 2001 Jul; 70(1):103-12. PubMed ID: 11435492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells.
    Sparwasser T; Koch ES; Vabulas RM; Heeg K; Lipford GB; Ellwart JW; Wagner H
    Eur J Immunol; 1998 Jun; 28(6):2045-54. PubMed ID: 9645386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of lipoteichoic acid and CpG-DNA during activation of innate immune cells.
    Dalpke AH; Frey M; Morath S; Hartung T; Heeg K
    Immunobiology; 2002 Oct; 206(4):392-407. PubMed ID: 12437070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC.
    Ramírez-Pineda JR; Fröhlich A; Berberich C; Moll H
    J Immunol; 2004 May; 172(10):6281-9. PubMed ID: 15128817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced murine macrophage TNF receptor shedding by cytosine-guanine sequences in oligodeoxynucleotides.
    Jin L; Raymond DP; Crabtree TD; Pelletier SJ; Houlgrave CW; Pruett TL; Sawyer RG
    J Immunol; 2000 Nov; 165(9):5153-60. PubMed ID: 11046047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG-containing oligodeoxynucleotides induce TNF-alpha and IL-6 production but not degranulation from murine bone marrow-derived mast cells.
    Zhu FG; Marshall JS
    J Leukoc Biol; 2001 Feb; 69(2):253-62. PubMed ID: 11272276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat plasmacytoid dendritic cells are an abundant subset of MHC class II+ CD4+CD11b-OX62- and type I IFN-producing cells that exhibit selective expression of Toll-like receptors 7 and 9 and strong responsiveness to CpG.
    Hubert FX; Voisine C; Louvet C; Heslan M; Josien R
    J Immunol; 2004 Jun; 172(12):7485-94. PubMed ID: 15187127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA.
    Jakob T; Walker PS; Krieg AM; Udey MC; Vogel JC
    J Immunol; 1998 Sep; 161(6):3042-9. PubMed ID: 9743369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synovial cytokine mRNA expression during arthritis triggered by CpG motifs of bacterial DNA.
    Deng GM; Tarkowski A
    Arthritis Res; 2001; 3(1):48-53. PubMed ID: 11178126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressive oligodeoxynucleotides inhibit CpG-induced inflammation of the mouse lung.
    Yamada H; Ishii KJ; Klinman DM
    Crit Care Med; 2004 Oct; 32(10):2045-9. PubMed ID: 15483413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent activation of microglial cells by Toll-like receptor agonists alone and in combination.
    Ebert S; Gerber J; Bader S; Mühlhauser F; Brechtel K; Mitchell TJ; Nau R
    J Neuroimmunol; 2005 Feb; 159(1-2):87-96. PubMed ID: 15652406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.